Citigroup’s Burning Rock Biotech BNR Stock Holding History

Citigroup’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16	Hold	1	–	–	﹤0.01%	5705
2025 Q4	$20	Buy	+1	New	+$15	﹤0.01%	5775
2025 Q1	–	Sell	-31	Closed	-$209	–	5604
2024 Q4	$209	Buy	+31	New	+$143	﹤0.01%	5661
2022 Q4	–	Sell	-6	Closed	–	–	5786
2022 Q3	$0	Hold	6	–	–	﹤0.01%	5844
2022 Q2	$0	Sell	6 -1,767	-100%	-$78.9K	﹤0.01%	6248
2022 Q1	$165K	Sell	1,773 -662	-27%	-$57.5K	﹤0.01%	4172
2021 Q4	$232K	Sell	2,435 -1,890	-44%	-$259K	﹤0.01%	4277
2021 Q3	$773K	Sell	4,325 -184	-4%	-$40.9K	﹤0.01%	3287
2021 Q2	$1.33M	Buy	4,509 +4,145	+1,139%	+$1.23M	﹤0.01%	3003
2021 Q1	$98K	Buy	+364	New	+$111K	﹤0.01%	4375

Other funds holding BNR

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

CRCM LP San Francisco, California $141M AUM 153.09% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RWMG

Redwood Wealth Management Group Medford, New Jersey $232M AUM 22.66% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

Citigroup's BNR Position: Q1 2026 in Review

Citigroup held its Burning Rock Biotech (BNR) position steady in Q1 2026 at 1 share worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #5705.

Citigroup first reported a position in BNR in Q1 2021 and has held it in 10 quarters since. The position peaked at $1.33M in Q2 2021. 16 funds tracked by Wall St. Rank hold BNR as of Q1 2026.

Citigroup held 1 share of Burning Rock Biotech worth $16 as of Q1 2026.
Citigroup left its Burning Rock Biotech share count unchanged in Q1 2026.
Burning Rock Biotech made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5705 holding.
Citigroup first reported a position in Burning Rock Biotech in Q1 2021 and has held it in 10 quarters since.
Citigroup's Burning Rock Biotech position peaked at $1.33M in Q2 2021.
16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.